Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Clinical trial NCT04696731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04696731
- Sponsor
- Allogene Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2030-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.